Press Releases
Search
-
24 Apr 2012
bioMérieux - First-Quarter 2012 Business Review
Sales up 9.3% at constant exchange rates Of which 3.1% organic growth, in line with objectives Strong momentum* in China (up 47%) and India (up 31%) Solid performance* in industrial applications (up 1...
-
12 Apr 2012
bioMérieux’s Myla® Named as Finalist in the 2012 Medical Design Excellence Awards
Myla middleware recognized for groundbreaking innovation in In Vitro Diagnostics...
-
27 Mar 2012
Detection of Schmallenberg virus made possible by bioMérieux: the ADIAGENE PCR kit has been validated by ANSES
Marcy l’Etoile, France – ADIAGENE, a member of the bioMérieux group and specialized in diagnostics for animal health, has obtained ANSES validation for a kit for the detection of Schmallenberg virus, ...
-
13 Mar 2012
bioMérieux - 2011 Financial Results
Solid financial performance: Sales at constant exchange rates: up 6.5% Including organic growth: up 4.1% Operating margin before non-recurring items: 18% Confirmed medium and long-term growth potentia...
-
14 Feb 2012
biomerieux-issues-reminder
Marcy l'Etoile - bioMérieux issues a reminder that on January 24, 2012, it set and communicated its objectives for 2012 sales growth. The Company is targeting organic growth between 3-5% or 6-8% at co...
-
24 Jan 2012
bioMérieux - 2011 Business Review
Sales: Up 6.5% at constant exchange rates Including 4.1% organic growth Double-digit growth* in 11 countries Including: India** (up 28%), China (up 20%), Brazil (up 18%) and Turkey (up 18%) Sustained ...